Imidazopiperidine amides as dipeptidyl peptidase IV inhibitors for the treatment of diabetes

Bioorg Med Chem Lett. 2007 Nov 1;17(21):5853-7. doi: 10.1016/j.bmcl.2007.08.030. Epub 2007 Aug 19.

Abstract

A series of substituted imidazopiperidine amides has been prepared and evaluated for inhibition of dipeptidyl peptidase IV (DPP-4). Substitution at the 1- and 3-positions produced increased selectivity for DPP-4 relative to DPP-8 and DPP-9. Compounds in this series had IC(50) values as low as 5.8 nM for inhibition of DPP-4.

MeSH terms

  • Amides / chemistry
  • Diabetes Mellitus / drug therapy*
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Humans
  • Hypoglycemic Agents / pharmacology*
  • Hypoglycemic Agents / therapeutic use
  • Piperidines / chemistry
  • Piperidines / pharmacology*
  • Piperidines / therapeutic use
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology*
  • Protease Inhibitors / therapeutic use

Substances

  • Amides
  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Piperidines
  • Protease Inhibitors